Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

141. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - Correct, the scope of the review is limited to 10 preventive services for cancer, cardiovascular disease … patients from all backgrounds are receiving evidence- based preventive services for individuals with cardiovascular

142. Supplemental Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-omega-3

143. Supplemental Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-omega-3/research

144. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - swollen first metatarsophalangeal joint) and risk factors (hyperuricemia, male sex, hypertension, or >1 cardiovascular … liver function abnormalities, nausea, arthralgia, and rash �� Rare but serious adverse effects include cardiovascular … prophylactic agents should be considered (e.g., possible contraindications of NSAIDs in patients with cardiovascular

145. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - market for prescription stimulants.8, 9 Misuse of prescription stimulants may be associated with cardiovascular … KQ2: What are the shorter term (e.g., overdose) and longer term (e.g., cardiovascular) health consequences … Comparator, if applicable • Outcome o Short-term  Overdoses, fatal and non-fatal  Health measures (cardiovascular

146. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - It should be stressed that in cardiovascular patients, the variability explained by the CYP2C19*2 is … This population is the most susceptible to adverse cardiovascular outcomes based on pharmacokinetic … High platelet reactivity by LTA was reported to be associated with all‐cause mortality, cardiovascular … High platelet reactivity by the VerifyNow P2Y12 Test was reported to be associated with cardiovascular … As already stated the number of events for cardiovascular mortality was tiny.

147. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
     July 01, 2012 - disease (<10%, 10 to 20% and >20%) based on the Framingham cardiovascular risk score to help determine … whether to recommend interventions to prevent 12-7 future cardiovascular events.34 Analyses of … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Assessing the role of circulating, genetic and imaging biomarkers in cardiovascular risk prediction … Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality

148. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Development and validation of improved algorithms for the assessment of global cardiovascular risk in … disease risk based on the Framingham cardiovascular risk score. … Development and validation of improved algorithms for the assessment of global cardiovascular risk in

149. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American … Development and validation of improved algorithms for the assessment of global cardiovascular risk in … disease risk based on the Framingham cardiovascular risk score. … Development and validation of improved algorithms for the assessment of global cardiovascular risk in

150. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
     November 01, 2024 - CRP: C-reactive protein; CVD: Cardiovascular disease; E/e’ ratio: early diastolic mitral inflow velocity … Discussion 40 Moreover, the improvements in cardiovascular outcomes, such as the reduction in … the E/e' ratio reported in one RCT, suggest that periodontal therapy might also offer cardiovascular … Influence of Periodontal Disease on Cardiovascular Markers in Diabetes Mellitus Patients. … Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the

151. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - • For Key Question 2, conclusions regarding cardiovascular morbidity and mortality are considered … mortality, cardiovascular and cerebrovascular morbidity, retinopathy, nephropathy, and neuropathy? … The risk of cardiovascular mortality was similar between metformin and each of the thiazolidinediones … Avandia (rosiglitazone)Previous (2010-2011) FDA and MHRA warnings of cardiovascular risks (elevated … Avandia (rosiglitazone)- Previous (2010-2011) FDA and MHRA warnings of cardiovascular risks (elevated

152. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - Unlike other major cardiovascular conditions, the burden of heart failure has continued to increase … Given that dose adjustment is not uncommon in the use of cardiovascular therapies, we allowed a “grace … Prior cardiovascular disease included acute coronary syndrome (acute myocardial infarction or unstable … As expected, there was a high prevalence of prior known cardiovascular disease as well as cardiovascular … Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

153. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - Methods for assessing pretest risk, defining cardiovascular outcomes, and defining usual care were … Some studies reported composite cardiovascular outcomes, which can be misleading, depending on the … Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular … Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular … Tomography, Society for Cardiovascular Magnetic Resonance, American College of Chest Physicians.

154. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - outcomes, including total cardiovascular disease, coronary heart disease, cardiovascular disease mortality … New observational studies identified for the current report (7 for total cardiovascular events, 17 … for cardiovascular death, 2 for ischemic heart disease, 6 for myocardial infarction, 8 for stroke, … outcomes, including total events and cardiovascular deaths. … Combined Vitamin D and Calcium and Cardiovascular Events For the original study, a variety of cardiovascular

155. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
     February 01, 2011 - morbidity, hospitalization, and mortality.2 Anemia, a common complication, conveys signifi- cant risk for cardiovascular … per dL.5 A number of published studies, beginning in the late 1990s,6 suggested potential adverse cardiovascular … intermittent KD and predialysis populations appears to decline upon publication of relevant studies (e.g., Cardiovascular … Treating anemia of chronic disease in the primary care set- ting: cardiovascular outcomes and manage

156. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Biologics neither decreased nor increased cardiovascular risks in the elderly. … Those with high- risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … Limited evidence does not suggest an increased risk of severe adverse events, including cardiovascular … Most studies found no risk of cardiovascular events and malignancy with biologic DMARDs, except for

157. Disposition of Comments_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertensive-disorders-pregnancy-disposition-comments.pdf
     May 31, 2023 - Author Response Commenter Section Comment Response Association of Black Cardiologists’ (ABC) Cardiovascular … transforms the peripheral (brachial) arterial pressure waveforms into central aortic pressures with cardiovascular … adults showed that central pulse pressure was 50% better than brachial pulse pressure in predicting cardiovascular … measurements may be useful in predicting preeclampsia and may play a role in the increased risk of future cardiovascular … Central pressure: variability and impact of cardiovascular risk factors.

158. renal-update-2015-150115 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
     January 15, 2015 - lipid-lowering drugs, and antiplatelet agents are all FDA approved for hypertension and/or reduction of cardiovascular … months) including blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular … depict studies sought to  address key questions formulated  in  this report Abbreviation: CVD, cardiovascular … defined by authors • CHF events, including flash pulmonary edema (including hospitalization) • Other cardiovascular … calendar years enrolled, follow-up duration, hypertension and blood pressure outcomes, kidney outcomes, cardiovascular

159. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
     March 10, 2010 - Most patients had hypertension in addition to other cardiovascular risk factors. … Telmisartan Randomized Assessment Study in Angiotensin- Converting Enzyme Inhibitor-Intolerant Patients with Cardiovascular … Given the known benefits of beta blockers and statins on cardiovascular morbidity and mortality, the … Results Pg 20, line 52- Why didn’t you think it reasonable to pool cardiovascular mortality and cardiac … We felt that cardiovascular mortality (which included death from vascular causes such as stroke) was

160. Home | AHRQ Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_prepublication-draft_20120523.pdf
     August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular